Marken adds multiple depot locations, boosts capacity for cell and gene 21-Jul-2020 By Ben Hargreaves Marken announces the addition of two depots in the US and Ukraine, as well as logistics branches in Ireland and the Netherlands.
Countries agree equitable COVID-19 vaccine access for 60% of globe 21-Jul-2020 By Ben Hargreaves WHO announces 165 countries look to ensure equal access to any vaccine for the novel coronavirus.
Catalent to invest $30m on clinical manufacturing site in France 21-Jul-2020 By Ben Hargreaves The company invests into its clinical biologics formulation development and drug fill-finish services.
GSK acquires 10% stake in CureVac, partner on mRNA vaccines 20-Jul-2020 By Ben Hargreaves GSK pushes to broaden its infectious disease pipeline by agreeing development deal with CureVac for five candidates.
Merck KGaA takes up option to license bispecific antibody 20-Jul-2020 By Ben Hargreaves The company opts into its second bispecific antibody through its partnership with F-star Therapeutics.
J&J to start P3 COVID-19 vaccine trials in September 20-Jul-2020 By Ben Hargreaves Moving on an accelerated timeline, the company seeks late September start date and to exceed 1bn doses by end of 2021.
IQVIA partners with AZ on COVID-19 vaccine clinical trials 16-Jul-2020 By Ben Hargreaves The two companies will work to set up clinical trials utilizing IQVIA’s Virtual Trial solutions.
Moderna releases positive early vaccine data, signs fill-finish deal 16-Jul-2020 By Ben Hargreaves The biotech provides more detail on Phase I study of its COVID-19 vaccine and agrees commercial fill-finish manufacturing.
Merck CEO: COVID-19 vaccine manufacture and distribution ‘huge issue’ 15-Jul-2020 By Ben Hargreaves Kenneth Frazier states manufacture of potential vaccine is ‘bigger challenge’ than developing an effective vaccine.
Takeda deal looks to bolster biologics pipeline 14-Jul-2020 By Ben Hargreaves Takeda partners with Twist Bioscience for access to platform to discover, validate and optimize antibodies in its pipeline.
Blackstone closes $4.6bn life sciences fund 14-Jul-2020 By Ben Hargreaves Blackstone Life Sciences completes first private fund to invest in treatments in late-stage development.
Dewpoint and Merck in $305m deal for HIV ‘cure’ 14-Jul-2020 By Ben Hargreaves The two partners will use Dewpoint’s platform, focusing on biomolecular condensates, to treat the disease.
BeiGene launches $2bn share offering, backed by Amgen 13-Jul-2020 By Ben Hargreaves Chinese biotech plans to raise the sum as working capital, as it looks to progress its pipeline.
Sanofi signs €875m deal with Kiadis 13-Jul-2020 By Ben Hargreaves Sanofi looks to supplement its Sarclisa therapy with investigational treatment to treat multiple myeloma.
Webinar delves into drug delivery innovations 09-Jul-2020 By Jenni Spinner Innovations in Drug Delivery Part II, a free online event on July 15, will feature novel technologies and innovative solutions to current challenges.
